Skip to main content
Clinical Trials/NCT05462665
NCT05462665CompletedNot Applicable

Evaluation of the Intravenous Tissue Plasminogen Activator Treatment Algorithm of Nursing Intern Students and Evaluation of the Efficiency of Simulation Method in the Development of Self-Efficacy Proficiency Levels

Dokuz Eylul University1 site in 1 country75 target enrollmentStarted: May 1, 2020Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
75
Locations
1
Primary Endpoint
self-efficacy scale

Study Overview

Brief Summary

Intravenous (IV) tissue plasminogen activator (tPA) is one of the key elements of acute ischemic stroke. In this study, acute stroke patients maximum benefit from the treatment, intravenous tissue plasminogen activator (IV tPA) minimizing the errors related to the treatment of acute ischemic stroke patients of nursing students from clinical practice guides published on the treatment of It is aimed to be informed and to standardize nursing interventions.

Detailed Description

Time management in acute stroke patients is possible with a multidisciplinary approach and team members who have received specific training for acute stroke patients. Studies have shown that the maximum result of treatment for acute stroke patients depends on nurses' ability to identify disease symptoms, plan and apply symptom-specific nursing care. There is evidence that the multidisciplinary presence of stroke teams in stroke units and the delivery of coordinated care during the acute phase improve patient outcomes . Coordinated care by the stroke team improves patient outcomes, reduces hospital costs, reduces patient readmission, and improves patient care quality.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Treatment
Masking
Single (Participant)

Masking Description

Intern nurses will be numbered from 1 to 75 and will be randomly divided into study and control groups from the random numbers table.

After the groups are determined by the randomization method, each intern nurse in the study and control groups will be interviewed face to face and their written informed consent will be obtained. Then, all nursing intern students participating in the research will be asked to fill in the IV tPA Treatment Knowledge Level Evaluation Form, Self-Efficacy Competence Scale. Intern nurses in both groups will be given 1-hour theoretical training on IV tPA treatment before, during and after the procedure. In addition, simulation-based training will be applied to the intern nurses in the study group regarding IV tPA treatment before, during and after the procedure.

Eligibility Criteria

Ages
18 Years to 30 Years (Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Intern nursing student at Dokuz Eylül University

Exclusion Criteria

  • •Those who did not agree to participate in the study Those who were not be intern

Arms & Interventions

intervention

Experimental

Nursing intern students (n:39) will be given theory training about tPA treatment

Intervention: theory training (Behavioral)

Control

Experimental

Nursing intern students (n:39) will be given theory training and simulation training about tPA treatment

Intervention: theory training (Behavioral)

Control

Experimental

Nursing intern students (n:39) will be given theory training and simulation training about tPA treatment

Intervention: theory and simulation training (Behavioral)

Outcomes

Primary Outcomes

self-efficacy scale

Time Frame: Change from baseline in Intravenous Tissue Plasminogen Activator Treatment knowledge and 2 weeks after intervention

Effectiveness change of Intravenous tissue plasminogen activator treatment knowledge after theoric teaching

simulation scale

Time Frame: 2 weeks after simulation training

evaluation the simulation design

tPA treatment information form

Time Frame: Change from baseline in Intravenous Tissue Plasminogen Activator Treatment knowledge and 2 weeks after intervention

Effectiveness change of Intravenous tissue plasminogen activator treatment knowledge after simulation and theoric teaching

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

OZGE SOYDANER

nurse

Dokuz Eylul University

Study Sites (1)

Loading locations...

Similar Trials